Carmel Capital Partners, LLC Bristol Myers Squibb CO Transaction History
Carmel Capital Partners, LLC
- $235 Million
- Q1 2025
A detailed history of Carmel Capital Partners, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Carmel Capital Partners, LLC holds 3,749 shares of BMY stock, worth $179,464. This represents 0.1% of its overall portfolio holdings.
Number of Shares
3,749
Previous 3,748
0.03%
Holding current value
$179,464
Previous $211,000
8.06%
% of portfolio
0.1%
Previous 0.09%
Shares
10 transactions
Others Institutions Holding BMY
# of Institutions
2,805Shares Held
1.59BCall Options Held
25.9MPut Options Held
23.9M-
Vanguard Group Inc Valley Forge, PA191MShares$9.16 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.59 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$5.17 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.54 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.18 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $102B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...